ARTICLE | Company News
Adherex cancer news
November 17, 2008 8:00 AM UTC
Adherex will rationalize its clinical programs to conserve cash. The company will focus on its Phase III trials of sodium thiosulfate (STS) to treat liver cancer and to prevent hearing loss in childre...